Vol 2005, No 59 (2005)

Table of Contents

Research & Development

Curis and Genentech Join Forces Again Abstract pdf
Business Review Editor

Features

Pfizer Validates Coley Pharmaceutical's ProMune#8482; with Deal Worth US$515 M Plus Abstract pdf
Business Review Editor
Abbott Takes First Pick at BioCurex Abstract pdf
Business Review Editor
Deal Making Trends of Top Pharma Companies Abstract pdf
Business Review Editor
Therapy Focus: Erectile Dysfunction Abstract pdf
Business Review Editor

Licensing

Arakis and Vectura in COPD Alliance with Novartis Abstract pdf
Business Review Editor
Tanox to Buy Sunol Tissue Factor Assets Abstract pdf
Business Review Editor

General

Gilead Begins to Fill the Hole in its Pipeline Abstract
Business Review Editor

Company Profile

ALTANA Pharma AG Abstract pdf
Business Review Editor

Distribution & Marketing

Competition Forces Organon and J&J to Terminate Co-Promotion of Risperdal® Abstract pdf
Business Review Editor

Business Commentaries

The Maturing of Biotech html
Fintan Walton

Deal Trackers

Alvesco (ciclesonide) Abstract pdf
Business Review Editor

Mergers & Acquisitions

Solvay Looks to Fournier to Expand Drugs Business Abstract pdf
Business Review Editor
IDM’s and Epimmune’s Merger Highlights Biotech Funding Difficulties Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.